Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-31

Clinical Trial Update: Effectiveness of UVA1-irradiation in the Treatment of Early Skin Fibrosis in Patients Suffering From Systemic Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

The document reports the termination of a Phase 1/2 clinical trial evaluating UVA1 irradiation for early skin fibrosis in systemic sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • UVA1 irradiation

Snippet

Sponsor: Nicolas Hunzelmann | Conditions: Systemic Scleroderma, Systemic Sclerosis | Phase 1, Phase 2 | Status: TERMINATED